Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Abendroth

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Plos One|March 24, 2021
Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoebaLogan Tillery, Kayleigh Barrett, Jenna Goldstein, et al.
Communications Biology|December 5, 2024
Exquisite selectivity of griselimycin extends to beta subunit of DNA polymerases from Gram-negative bacterial pathogensMichael K Fenwick, Phillip G Pierce, Jan Abendroth, et al.
Tuberculosis (Edinburgh, Scotland)|January 24, 2015
Increasing the structural coverage of tuberculosis drug targetsLoren Baugh, Isabelle Phan, Darren W Begley, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Plos One|March 24, 2021
Naegleria fowleri: Protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoebaLogan Tillery, Kayleigh Barrett, Jenna Goldstein, et al.
Communications Biology|December 5, 2024
Exquisite selectivity of griselimycin extends to beta subunit of DNA polymerases from Gram-negative bacterial pathogensMichael K Fenwick, Phillip G Pierce, Jan Abendroth, et al.
Tuberculosis (Edinburgh, Scotland)|January 24, 2015
Increasing the structural coverage of tuberculosis drug targetsLoren Baugh, Isabelle Phan, Darren W Begley, et al.
Journal of Medicinal Chemistry|October 10, 2022
Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of <b>UCB7362</b>Martin A Lowe, Alvaro Cardenas, Jean-Pierre Valentin, et al.
Pageof 11